• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估中国围生期心肌病患者结局的新风险评分。

A new risk score for the assessment of outcomes for Chinese patients with peripartum cardiomyopathy.

机构信息

Department of Cardiology, Xiamen Key Laboratory of Cardiac Electrophysiology, Xiamen Institute of Cardiovascular Diseases, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361003, China.

Department of Echocardiography, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361003, China.

出版信息

Heart Lung. 2023 Jul-Aug;60:81-86. doi: 10.1016/j.hrtlng.2023.02.021. Epub 2023 Mar 16.

DOI:10.1016/j.hrtlng.2023.02.021
PMID:36933287
Abstract

BACKGROUND

Peripartum cardiomyopathy (PPCM) is a potentially life-threatening complication of pregnancy, but identifying patients at higher risk of this condition remains difficult.

OBJECTIVES

We conducted a study to identify new risk factors associated with PPCM and predictors of poor outcomes.

METHODS

This retrospective analysis included a total of 44 women with PPCM. As a control group, 79 women who gave birth around the same time as the PPCM patients and who did not have organic disease were included. A multivariate regression analysis was conducted to identify risk factors associated with PPCM and with delayed recovery.

RESULTS

All PPCM patients were discharged within 28 days. In comparison to the control group, PPCM patients had higher rates of preeclampsia (20.4% vs. 1.27%, P<0.001), autoimmune disease (27.3% vs. 11.4%, P = 0.018), and cesarean delivery with preterm labor (31.8% vs. 17.7%, P = 0.037). The neonates of PPCM patients had lower birth weight (2.70±0.66 kg vs. 3.21±0.57 kg, P<0.001). PPCM patients had higher levels of C-reactive protein, d-dimer, brain natriuretic peptide (BNP), and serum phosphorus, but lower levels of albumin and serum calcium (all P<0.001). In all patients with PPCM, the left ventricular ejection fraction (LVEF) returned to normal (≥50%) within 28 days after admission. Subjects with early recovery (n = 34) had lower BNP than those with delayed recovery (n = 10) (649.7 ± 526.0 pg/mL vs. 1444.1 ± 1040.8 pg/mL, P = 0.002). Multivariate regression led to a three-point score system to predict PPCM (1 point each for the presence of pericardial effusion, left ventricular dilatation, and d-dimer level ≥0.5 μg/mL). At a cutoff of ≥2, this scoring system predicted delayed recovery with 95.5% sensitivity and 96.1% specificity. The negative predictive value was 97.4% and the positive predictive value was 93.3%. Binary logistic regression indicated that PPCM patients with pulmonary hypertension, lower hemoglobin, or worse LVEF tended to require longer hospital stay (minimum 14 days).

CONCLUSIONS

A risk score that consists of pericardial effusion, left ventricular dilatation, and d-dimer level ≥ 0.5 μg/mL could help streamline the diagnosis of PPCM prior to confirmatory investigations. Moreover, a risk score that consists of pulmonary hypertension, lower hemoglobin and worse LVEF could help to predict poor outcomes in PPCM patients.

摘要

背景

围产期心肌病(PPCM)是妊娠的一种潜在危及生命的并发症,但识别出处于这种疾病更高风险的患者仍然很困难。

目的

我们进行了一项研究,以确定与 PPCM 相关的新危险因素和不良预后的预测因素。

方法

这项回顾性分析共纳入了 44 名 PPCM 患者。作为对照组,纳入了 79 名在同一时期分娩且无器质性疾病的妇女。进行多变量回归分析以确定与 PPCM 相关的危险因素以及与延迟恢复相关的危险因素。

结果

所有 PPCM 患者均在 28 天内出院。与对照组相比,PPCM 患者的子痫前期发生率更高(20.4% vs. 1.27%,P<0.001)、自身免疫性疾病发生率更高(27.3% vs. 11.4%,P=0.018)、剖宫产合并早产发生率更高(31.8% vs. 17.7%,P=0.037)。PPCM 患者的新生儿出生体重较低(2.70±0.66kg vs. 3.21±0.57kg,P<0.001)。PPCM 患者的 C 反应蛋白、D-二聚体、脑钠肽(BNP)和血清磷水平较高,而白蛋白和血清钙水平较低(均 P<0.001)。所有 PPCM 患者的左心室射血分数(LVEF)在入院后 28 天内均恢复正常(≥50%)。早期恢复的患者(n=34)的 BNP 低于延迟恢复的患者(n=10)(649.7±526.0pg/mL vs. 1444.1±1040.8pg/mL,P=0.002)。多变量回归得出了一个三点评分系统来预测 PPCM(各有 1 分,分别为心包积液、左心室扩张和 D-二聚体水平≥0.5μg/mL)。当截断值≥2 时,该评分系统以 95.5%的灵敏度和 96.1%的特异性预测延迟恢复。阴性预测值为 97.4%,阳性预测值为 93.3%。二项逻辑回归表明,患有肺动脉高压、血红蛋白较低或 LVEF 较差的 PPCM 患者往往需要更长的住院时间(至少 14 天)。

结论

一种由心包积液、左心室扩张和 D-二聚体水平≥0.5μg/mL 组成的评分系统有助于在进行确认性检查之前简化 PPCM 的诊断。此外,一种由肺动脉高压、较低的血红蛋白和更差的 LVEF 组成的评分系统可以帮助预测 PPCM 患者的不良预后。

相似文献

1
A new risk score for the assessment of outcomes for Chinese patients with peripartum cardiomyopathy.一种用于评估中国围生期心肌病患者结局的新风险评分。
Heart Lung. 2023 Jul-Aug;60:81-86. doi: 10.1016/j.hrtlng.2023.02.021. Epub 2023 Mar 16.
2
Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.围生期心肌病中心肌 T1 和 T2 mapping 评估左心室功能的恢复:一项心血管磁共振研究。
J Cardiovasc Magn Reson. 2020 Jan 6;22(1):2. doi: 10.1186/s12968-019-0590-z.
3
Importance of Early Diagnosis in Peripartum Cardiomyopathy.围生期心肌病早期诊断的重要性。
Hypertension. 2020 Jan;75(1):91-97. doi: 10.1161/HYPERTENSIONAHA.119.13291. Epub 2019 Nov 11.
4
Predicting poor left ventricular function recovery in Peripartum cardiomyopathy.预测围生期心肌病患者左心室功能不良的恢复情况。
J Matern Fetal Neonatal Med. 2023 Dec;36(2):2279018. doi: 10.1080/14767058.2023.2279018. Epub 2023 Nov 7.
5
Incidence, Risk Factors, Maternal and Neonatal Outcomes of Peripartum Cardiomyopathy (PPCM) in Oman.阿曼围生期心肌病(PPCM)的发病率、危险因素、母婴结局。
Glob Heart. 2023 May 2;18(1):23. doi: 10.5334/gh.1198. eCollection 2023.
6
Peripartum women with dyspnea in the emergency department: Is it peripartum cardiomyopathy?急诊科出现呼吸困难的围产期女性:是围产期心肌病吗?
Medicine (Baltimore). 2018 Aug;97(31):e11516. doi: 10.1097/MD.0000000000011516.
7
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.围生期心肌病女性患者的高血压病:ESC EORP PPCM 注册研究的新认识。
Eur J Heart Fail. 2021 Dec;23(12):2058-2069. doi: 10.1002/ejhf.2264. Epub 2021 Aug 25.
8
Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.伊拉克围产期心肌病:基于初始登记的资料和 6 个月的结局。
ESC Heart Fail. 2021 Oct;8(5):4048-4054. doi: 10.1002/ehf2.13502. Epub 2021 Jun 28.
9
Electrocardiographic findings in peripartum cardiomyopathy.围生期心肌病的心电图表现。
Clin Cardiol. 2019 May;42(5):524-529. doi: 10.1002/clc.23171. Epub 2019 Mar 29.
10
In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.在围产期心肌病中,纤溶酶原激活物抑制剂-1 是一个具有争议性作用的潜在新生物标志物。
Cardiovasc Res. 2020 Sep 1;116(11):1875-1886. doi: 10.1093/cvr/cvz300.

引用本文的文献

1
The implication of pericardial effusion in the third trimester for preeclampsia and heart failure in high-risk pregnant women.孕晚期心包积液对高危孕妇先兆子痫和心力衰竭的影响。
J Echocardiogr. 2025 Jan 5. doi: 10.1007/s12574-024-00679-3.
2
Pharmacological interventions for peripartum cardiomyopathy.围生期心肌病的药物干预。
Cochrane Database Syst Rev. 2024 Oct 30;10(10):CD014851. doi: 10.1002/14651858.CD014851.
3
Peripartum cardiomyopathy: a comprehensive and contemporary review.围生期心肌病:全面而现代的综述。
Heart Fail Rev. 2024 Nov;29(6):1261-1278. doi: 10.1007/s10741-024-10435-5. Epub 2024 Sep 30.
4
Risk Factors and Clinical Features of Peripartum Cardiomyopathy in a Chinese Population.中国人群围产期心肌病的危险因素及临床特征
J Multidiscip Healthc. 2024 Aug 5;17:3763-3772. doi: 10.2147/JMDH.S468377. eCollection 2024.